This trial compares two different treatments for the same medical condition to see which works better.
1 Primary · 11 Secondary · Reporting Duration: Week 4, 8, 16, 24, 36, and 48
Side Effects for
2 Treatment Groups
Juvéderm® Voluma™ XC
1 of 2
saypha® VOLUME Lidocaine
1 of 2
486 Total Participants · 2 Treatment Groups
Primary Treatment: saypha® VOLUME Lidocaine · No Placebo Group · Phase 3
Who is running the clinical trial?
Age 22 - 75 · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
- "Very interested in your study please contact me"
What questions have other patients asked about this trial?
- "How long is the study ?"
How many prior treatments have patients received?
Frequently Asked Questions
Does this clinical trial accept volunteers over the age of twenty?
"This trial seeks adult participants younger than 75 and older than 22 years of age." - Anonymous Online Contributor
Are there still opportunities for volunteers to participate in the trial?
"As noted on clinicaltrials.gov, this investigation is actively in need of participants. It was initially posted online on August 16th 2022 and underwent its most recent update during February 21st 2023." - Anonymous Online Contributor
How risky is the utilization of saypha® VOLUME Lidocaine for patients?
"Testing and evaluation of saypha® VOLUME Lidocaine has yielded a safety rating 3, due to the multiple rounds of data that support its efficacy and corroborate its safety." - Anonymous Online Contributor
How extensive is the geographic reach of this clinical investigation?
"This trial is currently operating out of 16 medical sites, some examples being Savannah, Scottsdale and Encino. In order to save time and effort, it would be wise for potential participants to select the clinic closest them when enrolling." - Anonymous Online Contributor
What is the current participant count for this research endeavor?
"For this research to be conducted, the sponsor Croma-Pharma GmbH needs 486 patients who meet their specified criteria. The trial will run out of multiple sites including Meridian Clinical Research, Georgia Plastic Surgery in Savannah and Clear Dermatology & Aesthetics Center in Scottsdale, Arizona." - Anonymous Online Contributor
Who would be a feasible candidate for this clinical experiment?
"This clinical trial is enrolling 486 participants aged between 22 and 75 who have moderate to severe midface volume loss. In order for individuals to be included in this study, they must meet the following requirements: Baseline treatment; inhabiting a certain age range (from 22 -75 years); having bilateral symmetric midface volume deficit (scored 2 or 3 on the 5-point Midface Volume Deficit Severity Scale); women of childbearing potential with negative urine pregnancy test results AND agreement to use highly effective birth control methods; males with female partners of childbearing potential agreeing to contraception throughout the research period; healthy skin not affected" - Anonymous Online Contributor